1-Chlorohexadecane

We are 1-Chlorohexadecane CAS:4860-03-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 4860-03-1
Product Name: 1-Chlorohexadecane
Other Name:
1-Cyclohexadecane
Palmityl chloride
1-Chlorhexadecan
1-chloro-hexadecane
Hexadecyl Chloride
chlorohexadecane
1-hexadecane chloride
hexadecanoyl chloride
 
Density: 0.9±0.1 g/cm3
Boiling Point: 321.8±5.0 °C at 760 mmHg
Melting Point: 8-14 °C(lit.)
Molecular Formula: C16H33Cl
Molecular Weight: 260.886
Flash Point: 138.1±3.4 °C
Exact Mass: 260.227081
LogP: 8.94
Vapour Pressure: 0.0±0.7 mmHg at 25°C
Index of Refraction: 1.446
Water Solubility: 0.02 g/L (20 ºC, Dec.)
Freezing Point: 17.9℃
 
Specification
Appearance: Colorless to light yellow transparent liquid
Assay: ≥99.0%
Water: ≤0.10%
 
Application
Organic synthesis intermediate, used as surfactant.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1-Chlorohexadecane


Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?Ácido 4-hidroxibenzoico CAS:99-96-7 This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?(S)-3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one CAS:850222-40-1 Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.902-04-5 In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.

Related Products
Product Name
(R)-(+)-2-(4-Hydroxyphenoxy)propionic acid View Details
2′,4′-Dichlorovalerophenone View Details
5-bromo-6-methoxypyridin-3-amine View Details
2-bromo-5-methyl-3-nitropyridine manufacturer 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol manufacturer tert-Butyl bromoacetate manufacturer 3-Methylbenzoic acid manufacturer 2,4,5-Trichloropyrimidine manufacturer